PMID- 23802067
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211021
IS  - 2162-4011 (Print)
IS  - 2162-402X (Electronic)
IS  - 2162-4011 (Linking)
VI  - 2
IP  - 3
DP  - 2013 Mar 1
TI  - Identification of human tissue cross-presenting dendritic cells: A new target for 
      cancer vaccines.
PG  - e23140
LID - e23140
AB  - Dendritic cells (DCs) are a heterogeneous group of functionally specialized 
      antigen-presenting cells. We recently characterized the human tissue 
      cross-presenting DCs and aligned the human and mouse DC subsets. Our findings 
      will facilitate the translation of murine DC studies to the human setting and aid 
      the design of DC-based vaccine strategies for infection and cancer immunotherapy.
FAU - Haniffa, Muzlifah
AU  - Haniffa M
AD  - Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne, UK.
FAU - Collin, Matthew
AU  - Collin M
FAU - Ginhoux, Florent
AU  - Ginhoux F
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Oncoimmunology
JT  - Oncoimmunology
JID - 101570526
PMC - PMC3661152
OTO - NOTNLM
OT  - XCR1
OT  - cross-presentation
OT  - dendritic cell
OT  - subset
OT  - transcriptomic analysis
EDAT- 2013/06/27 06:00
MHDA- 2013/06/27 06:01
PMCR- 2013/03/01
CRDT- 2013/06/27 06:00
PHST- 2012/12/01 00:00 [received]
PHST- 2012/12/05 00:00 [accepted]
PHST- 2013/06/27 06:00 [entrez]
PHST- 2013/06/27 06:00 [pubmed]
PHST- 2013/06/27 06:01 [medline]
PHST- 2013/03/01 00:00 [pmc-release]
AID - 2012ONCOIMM0388 [pii]
AID - 10.4161/onci.23140 [doi]
PST - ppublish
SO  - Oncoimmunology. 2013 Mar 1;2(3):e23140. doi: 10.4161/onci.23140.